Hematologic Diseases: Clinical Trials

29 trials for Hematologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 suspended. 29 Phase 2, 13 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 229Suspended 29
Phase 113Suspended 13

Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pyronaridine in Acute Myeloid Leukemia (AML)
Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL)
Phase 2SuspendedArmaceutica, Inc.2002028-02-212026-10-19
Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)
Allogeneic umbilical cord mesenchymal stem cells, Decitabine - Myelodysplastic Syndromes
Phase 1 / Phase 2SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
Mirdametinib, Sirolimus - Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma (RRMM)
Phase 1 / Phase 2SuspendedNational Cancer Institute (NCI)542026-11-232026-11-18
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
Phase 2SuspendedUniversity of Washington302026-05-082026-09-29
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia
Phase 2SuspendedLeland Metheny202026-04-082026-09-10
Ascorbate in Myelodysplastic Syndrome
High-dose ascorbate, Azacitidine - Myelodysplastic Syndromes
Phase 2SuspendedPrajwal Dhakal382026-03-112026-10-09
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Plerixafor, Gcsf - Multiple Myeloma, Hodgkin Lymphoma
Phase 2SuspendedThomas Jefferson University1002025-10-162026-11-18
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Extramedullary Disease in Multiple Myeloma, Multiple Myeloma
Phase 1 / Phase 2SuspendedCity of Hope Medical Center202025-08-292026-10-07
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
Eltrombopag (EPAG) - Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
Phase 2SuspendedAbhay Singh, MD MPH252025-06-172026-10-09
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL
Phase 1 / Phase 2SuspendedSymBio Pharmaceuticals432025-06-092026-02-05
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Iberdomide, Belantamab Mafodotin, Dexamethasone - Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Phase 1 / Phase 2SuspendedAlliance for Clinical Trials in Oncology882025-04-232026-10-02
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma
Phase 2SuspendedNational Cancer Institute (NCI)842024-08-272026-10-19
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
Dasatinib - Acute Myeloid Leukemia
Phase 2SuspendedInstitut Paoli-Calmettes352024-05-222026-10-01
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
Carfilzomib, Iberdomide, Oral Dexamethasone - Multiple Myeloma
Phase 1 / Phase 2SuspendedHackensack Meridian Health662022-05-132026-07-13
Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Lenalidomide, Luspatercept - Myelodysplastic Syndromes
Phase 1 / Phase 2SuspendedMikkael Sekeres, MD502021-11-092026-07-17
Two Step Haplo With Radiation Conditioning
Fludarabine, Total-Body Irradiation, Donor Lymphocyte Infusion - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2SuspendedThomas Jefferson University632021-10-252026-11-18
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
fadraciclib - Leukemia, Myelodysplastic Syndrome(MDS)
Phase 1 / Phase 2SuspendedCyclacel Pharmaceuticals, Inc.2102021-10-222024-02-08
Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia
IBI188, Azacitidine, Decitabine - Acute Myeloid Leukemia
Phase 1 / Phase 2SuspendedInnovent Biologics (Suzhou) Co. Ltd.2222020-09-252023-10-23
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
NEXI-002 T Cells - Relapsed Refractory Multiple Myeloma
Phase 1 / Phase 2SuspendedNexImmune Inc.92020-08-172024-01-16
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2SuspendedCuris, Inc.3662020-07-062026-03-19

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Myelodysplastic Syndromes (12)  ·  Leukemia, Myeloid, Acute (9)  ·  Multiple Myeloma (8)  ·  Leukemia (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Hodgkin Disease (3)  ·  Leukemia, Myelomonocytic, Chronic (3)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Neoplasms (2)  ·  Primary Myelofibrosis (2)  ·  Recurrence (2)

Broader conditions

Hemic and Lymphatic Diseases (29)  ·  Neoplasms by Histologic Type (24)  ·  Neoplasms (22)  ·  Immune System Diseases (16)  ·  Immunoproliferative Disorders (15)  ·  Lymphoproliferative Disorders (15)  ·  Leukemia (13)  ·  Bone Marrow Diseases (12)  ·  Leukemia, Myeloid (10)  ·  Lymphatic Diseases (9)  ·  Blood Protein Disorders (8)  ·  Cardiovascular Diseases (8)  ·  Hemorrhagic Disorders (8)  ·  Hemostatic Disorders (8)

Interventions

Magnetic Resonance Spectroscopy (4)  ·  Specimen Handling (4)  ·  Biopsy (3)  ·  Cyclophosphamide (3)  ·  iberdomide (3)  ·  Ascorbic Acid (2)  ·  Azacitidine (2)  ·  Decitabine (2)  ·  Dexamethasone (2)  ·  Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Mycophenolic Acid (2)  ·  Tacrolimus (2)  ·  Whole-Body Irradiation (2)  ·  X-Rays (2)

Sponsors

National Cancer Institute (NCI) (2)  ·  Thomas Jefferson University (2)  ·  Abhay Singh, MD MPH (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Armaceutica, Inc. (1)  ·  BioMAS Ltd (1)  ·  City of Hope Medical Center (1)  ·  Curis, Inc. (1)  ·  Cyclacel Pharmaceuticals, Inc. (1)  ·  Hackensack Meridian Health (1)  ·  Humanigen, Inc. (1)  ·  Innovent Biologics (Suzhou) Co. Ltd. (1)  ·  Institut Paoli-Calmettes (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Leland Metheny (1)

Countries

United States (16)  ·  China (5)  ·  France (2)  ·  Israel (2)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Poland (1)  ·  Senegal (1)  ·  Singapore (1)  ·  South Korea (1)

Top investigators

Abhay Singh, MD, MPH (1)  ·  Elizabeth M Hill, M.D. (1)  ·  Jiong HU, M.D., (1)  ·  Juan Sierra-Madero, MD (1)  ·  Jun Zhu, M.D. (1)  ·  Kristi Jones (1)  ·  Lei Guo (1)  ·  Leland Metheny, MD (1)  ·  Mikkael Sekeres, MD (1)  ·  Mitchell Sabloff (1)  ·  Morgan Lam (1)  ·  Moshe Gatt, MD (1)  ·  Noa Biran, MD (1)  ·  Prajwal Dhakal, MD (1)  ·  Renato J Aguilera, PhD (1)

Results publications

PMID 12628464, PMID 14557216, PMID 16249702, PMID 17273548, PMID 19284416, PMID 19645607, PMID 20651586, PMID 21403129, PMID 21921156, PMID 22632127, PMID 27736729, PMID 29093707, PMID 9204894, PMID 9461195

NIH funding

P30CA033572 (1), U10CA180821 (1)